Tactile Systems Technology (TCMD) Cash from Investing Activities (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,123.74% |
| Dec 31, 2025 | 50.00% |
| Sep 30, 2025 | -190.68% |
| Jun 30, 2025 | 2.46% |
| Mar 31, 2025 | 17.28% |
| Dec 31, 2024 | 49.69% |
| Sep 30, 2024 | -86.29% |
| Jun 30, 2024 | -4.58% |
| Mar 31, 2024 | 46.60% |
| Dec 31, 2023 | -135.59% |
| Sep 30, 2023 | 53.11% |
| Jun 30, 2023 | -192.44% |
| Mar 31, 2023 | -347.69% |
| Dec 31, 2022 | 95.45% |
| Sep 30, 2022 | -492.53% |
| Jun 30, 2022 | -37.71% |
| Mar 31, 2022 | 81.52% |
| Dec 31, 2021 | 98.82% |
| Sep 30, 2021 | -18,532.87% |
| Jun 30, 2021 | -38.91% |
| Mar 31, 2021 | 38.42% |
| Dec 31, 2020 | -110.20% |
| Sep 30, 2020 | -19.13% |
| Jun 30, 2020 | -36.24% |
| Mar 31, 2020 | 906.92% |
| Dec 31, 2019 | 113.62% |
| Sep 30, 2019 | -63,563.64% |
| Jun 30, 2019 | -100.30% |
| Mar 31, 2019 | 139.22% |
| Dec 31, 2018 | -4,476.96% |
| Sep 30, 2018 | 102.17% |
| Jun 30, 2018 | -319.20% |
| Mar 31, 2018 | 655.04% |
| Dec 31, 2017 | 43.63% |
| Sep 30, 2017 | 26.11% |
| Jun 30, 2017 | 79.75% |
| Mar 31, 2017 | 13.67% |
| Dec 31, 2016 | -4,945.54% |
| Sep 30, 2016 | -8.74% |
| Jun 30, 2016 | -83.93% |
| Mar 31, 2016 | 36.72% |
| Dec 31, 2015 | 0.00% |